High-Content Analysis Tools for Developmental Toxicity Screens in Zebrafish
High-Content Analysis Tools for Developmental Toxicity Screens in Zebrafish
批准号:
7749330
负责人:
Musodiq O Bello
金额:
$20.32万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-14 至 2011-06-30
关键词:
AlgorithmsAnatomyAnimal ModelAnimalsAreaAtlasesAutomationBiological AssayBladderCell Culture TechniquesCellsCollectionComputer softwareContractsCulture MediaDataDefectDevelopmentDevicesDimethyl SulfoxideDisease modelDrug IndustryEdemaEnvironmental PollutionEvaluationEyeFertilizationGastrointestinal tract structureGovernmentHeadHealthcareHeartImageImage AnalysisJawJointsLengthLiverManualsMeasurableMeasurementMeasuresModelingOrganPenicillinsPericardial body locationPersonsPharmaceutical PreparationsPhasePoisonPreclinical Drug EvaluationProcessQuantitative EvaluationsReaderReagentResearchSafetySamplingScientistScreening procedureSlideStagingStandardizationSwimmingSystemTailTeratogensToxic effectTretinoinUnited States Environmental Protection AgencyValidationValproic AcidVariantWidthZebrafishalitretinoinbasecosthigh throughput screeninginstrumentationnotochordprogramspublic health relevancesoftware developmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The zebrafish has become an important new animal model for drug screening, target identification, and validation of various disease models. Although progress has been made in adapting image based high- content screening systems, there are several challenges for automation. To date, the quantitative evaluation of zebrafish assays is performed semi-manually at best, which constitutes a significant bottleneck in terms of workflow and screening cost. In Phase I research, we will specialize software algorithms that will enable automated quantitative assessment of various toxicity endpoints, thus allowing the screening of a large number of potentially toxic compounds.
PUBLIC HEALTH RELEVANCE: Use of zebrafish as an alternative animal model for drug screening can greatly accelerate the drug screening process, decrease costs, and provide more accurate results than cell-based assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金